mjzanon - Brazil IP counsel for foreign law firms, agents and in-house teams. - Page 180

Merck Turns to Blockchain to Tackle Counterfeit Drugs

Spencer Shaw, GlobalData Healthcare Analyst Pharma giant Merck is seeking a patent for a blockchain-based system to track objects as

Biosimilars Provide Potentially Huge Cost-Saving Opportunities – Can These be Implemented Worldwide to Promote Sustainability?

Chloé Thépaut, MRes, GlobalData, Oncology and Hematology Senior Analyst An educational session (funded by a grant from Sandoz) entitled ‘Biosimilars

Global Innovation Index 2018 Report Now Available

The Global Innovation Index (GII) provides detailed metrics about the innovation performance of 126 countries which represent 90.8% of

Secto Design: Making use of design rights when competing with infringers

Design protection is sometimes undervalued, being considered after patent and trade mark rights for businesses when it comes to IP

Rituximab Biosimilars – Is the Hype Warranted?

Isabel Diez-Sevilla, PhD, GlobalData Oncology Analyst Kamagra tablets are prescribed levitra on line to the ED patients. If a loved

Brazil IP counsel for foreign law firms, agents and in-house teams.